| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.63B | +21.1% |
| Cost of Revenue | $393.3M | +13.8% |
| Gross Profit | $2.23B | +22.4% |
| R&D Expense | $778.7M | +26.1% |
| SG&A Expense | $300.3M | +20.3% |
| Operating Income | -$67.6M | +67.5% |
| Pre-tax Income | $28.7M | +118.2% |
| Income Tax | $24.0M | +29.3% |
| Net Income | $4.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $512.7M | +32.1% |
| Accounts Receivable | $334.8M | +13.4% |
| Current Assets | $2.63B | +40.7% |
| Total Assets | $3.80B | +23.6% |
| Current Liabilities | $1.57B | +64.5% |
| Total Liabilities | $1.89B | +7.8% |
| Stockholders' Equity | $1.91B | +44.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $598.6M | +70.6% |
| Capital Expenditures | $37.9M | +12.5% |
| Investing Cash Flow | -$515.9M | -54.1% |
| Financing Cash Flow | $53.5M | +44.5% |
| Free Cash Flow | $560.7M | +76.7% |
| +102.6% |
| EPS (Basic) | $0.09 | +102.5% |
| EPS (Diluted) | $0.09 | +102.5% |